Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 451-456

  Claxton, Christie R ^b   Brands, Michael W ^a,c   Fitzgerald, Sharyn M ^a   Cameron, Joseph A ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Endothelium; Glomerular filtration rate; Insulin

Indexed keywords

GLUCOSE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; BLOOD FLOW; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; GLUCOSE INFUSION; HEART RATE; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033956856     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.451     Document Type: Conference Paper

References (45)

1. Bohlen HG, Lash JM. Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. Am J Physiol. 1995;268: H2366-H2374.
2. Poston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci. 1995;88:245-255.
3. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes. Hypertension. 1998;31:1047-1060.
4. Pflueger AC, Osswald H, Knox FG. Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide. Am J Physiol. 1999;276:F340-F346.
5. Craven PA, DeRubertis FR, Melhem M. Nitric oxide in diabetic nephropathy. Kidney Int. 1997;52(suppl 60):S-46-S-53.
6. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764-770.
7. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest. 1996;97:2601-2610.
8. Hwang I-S, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512-516.
9. Verma S, Bhanot S, Yao L, McNeill JH. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens. 1996; 9:370-376.
10. Iyer SN, Katovich MJ. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Am J Hypertens. 1996;9:662-668.
11. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 1997;29:691-699.
12. Kotchen TA, Reddy S, Zhang HY. Increasing insulin sensitivity lowers blood pressure in the fructose-fed rat. Am J Hypertens. 1997;10: 1020-1026.
13. Katakam PVG, Ujhelyi MR, Hoenig ME, Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol. 1998;275:R788-R792.
14. Manning RDJ, Hu L, Mizelle HL, Montani J-P, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension. 1993;22:40-48.
15. Hu L, Manning RDJ, Brands MW. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 1994;23:185-194.
16. Brands MW, Harrison DL, Keen HL, Garnder A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension. 1997;29:1014-1019.
17. Keen HL, Brands MW, Smith MJ Jr, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension. 1998;31:637-642.
18. Keen HL, Brands MW, Smith MJJ, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats. Am J Hypertens. 1997;10:1125-1131.
19. Verma S, Bhanot S, McNeill JH. Effect of chronic endothelin blockade in hyperinsulinemic hypertensive rats. Am J Physiol. 1995;269: H2017-H2021.
20. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab. 1995;80:829-835.
21. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 1999;100:820-825.
22. Brands MW, Fitzgerald SM. Chronic intravenous glucose infusion causes moderate hypertension in rats. Am J Hypertens. In press.
23. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension. 1992; 19(suppl I):I-83-I-89.
24. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 1991;260:R764-R768.
25. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats. Am J Physiol. 1996;271:R276-R281.
26. Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats. Am J Hypertens. 1996;9:1192-1199.
27. Chen Y-L, Messina EJ. Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Phvsiol. 1996;270:H2120-H2124.
28. Kahn AM, Husid A, Allen JC, Seidel CL, Song T. Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway. Hypertension. 1997;30:928-933.
29. Baron AD. Hemodynamic actions of insulin. Am J Physiol. 1994;267: E187-E202.
30. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 1997;96:25-28.
31. Graier WF, Simecek S, Kukovetz WR, Kostner GM. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes. 1996;45:1386-1395.
32. Berger EY, Farber SJ, Earle DP Jr. Comparison of the constant infusion and urine collection techniques for the measurement of renal function. J Clin Invest. 1948;27:710-719.
33. Bruning J, Kintz BL. Computational Handbook of Statistics. Glenview, Ill: Scott, Foresman and Co; 1987.,
34. Koopmans SJ, Ohman L, Haywood JR, Mandarino LJ, DeFronzo RA. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in normal rats. Diabetes. 1997;46: 1572-1578.
35. Greenberg SS, Peevy K, Tanaka TP. Endothelium-derived and intraneuronal nitric oxide-dependent inhibition of norepinephrine efflux from sympathetic nerves by bradykinin. Am J Hypertens. 1991;4: 464-467.
36. Toda N, Kitamura Y, Okamura T. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension. 1993;21:3-8.
37. Cunha RS, Cabrai AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens. 1993;6:806-809.
38. Wilcox CS, Welch WJ. Macula densa nitric oxide synthase: expression, regulation, and function. Kidney Int. 1998;54(suppl 67):S-53-S-57.
39. Braam B, Koomans HA. Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int. 1995;48:1406-1411.
40. Schnermann JB, Briggs JP. Effect of angiotensin and other pressor agents on tubuloglomerular feedback responses. Kidney Int. 1990;38(suppl 30): S-77-S-80.
41. Braam B, Mitchell KD, Koomans HA, Navar LG. Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J Am Soc Nephrol. 1993;4:1257-1274.
42. Turkstra E, Boer P, Braam B, Koomans HA. Increased availability of nitric oxide leads to enhanced nitric oxide dependency of tubuloglomerular feedback in the contralateral kidney of rats with 2-kidney, 1-clip Goldblatt hypertension. Hypertension. 1999;34:679-684.
43. Dubey RK, Boegehold MA, Gillespie DG, Rosselli M. Increased nitric oxide activity in early renovascular hypertension. Am J Physiol. 1996; 270:R118-R124.
44. Huang WC, Tsai RY. Nitric oxide synthesis inhibition retards surgical reversal of one-kidney Goldblatt hypertension in rats. Hypertension. 1998;32:534-540.
45. Habler H-J, Wasner G, Janig W. Attenuation of neurogenic vasoconstriction by nitric oxide in hindlimb microvascular beds of the rat in vivo. Hypertension. 1997;30:957-961.